Economics at your fingertips  

Demand for a Transgenic Food with a Medical Benefit

Yoko Saito and Hisamitsu Saito

MPRA Paper from University Library of Munich, Germany

Abstract: The perceived health and environmental risks of genetically modified (GM) technology have impeded its diffusion in developed countries. However, GM crops, which can provide direct consumer as well as producer value, have recently been developed. This study applies a stated choice experiment to examine whether the addition of a medical benefit can improve the welfare of the beneficiaries of the newly developed GM variety. Our results show a tradeoff between general worries over GM technology and GM food’s specific health benefits. A marketing program should therefore be designed to inform and persuade consumers of these features.

Keywords: genetically modified research design; health; stated-preference method. (search for similar items in EconPapers)
JEL-codes: D12 I10 Q13 (search for similar items in EconPapers)
Date: 2015-11-18
New Economics Papers: this item is included in nep-agr, nep-dcm, nep-hea and nep-mkt
References: View references in EconPapers View complete reference list from CitEc

Downloads: (external link) original version (application/pdf)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link:

Access Statistics for this paper

More papers in MPRA Paper from University Library of Munich, Germany Ludwigstraße 33, D-80539 Munich, Germany. Contact information at EDIRC.
Bibliographic data for series maintained by Joachim Winter ().

Page updated 2024-07-07
Handle: RePEc:pra:mprapa:67945